✦ LIBER ✦

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer

✍ Scribed by S. Hohaus; S. Martin; A. Schneeweiß; M. T. Voso; R. F. Schlenk; D. Wallwiener; G. Bastert; R. Haas

Publisher: Springer
Year: 1999
Tongue: English
Weight: 105 KB
Volume: 44
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800051110

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with peripheral b

High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer

✍ Peter Bojko; Max Ernst Scheulen; Ralf Hilger; Carsten Oberhoff; Adolf Eduard Sch 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 107 KB

High dose chemotherapy with peripheral b

High dose chemotherapy with peripheral blood progenitor support in metastatic breast cancer

✍ U. Nitz; S. Mohrmann; H. G. Bender 📂 Article 📅 1999 🏛 Springer 🌐 German ⚖ 108 KB

Adjuvant therapy with high-dose medroxyp

Adjuvant therapy with high-dose medroxyprogesterone acetate for operable breast cancer

✍ Hiroki Koyama; Breast Cancer Collaborative Group for Medroxyprogesterone Acetate 📂 Article 📅 1999 🏛 Springer Japan 🌐 English ⚖ 771 KB

P53 is the strongest predictor of surviv

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen

Ceftazidime in combination with glycopep

Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support

✍ G. Egerer; H. Goldschmidt; N. Streich; I. Ehrhard; H. G. Sonntag; R. Haas 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 72 KB

The antiemetic efficacy of granisetron p

The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support

✍ M. A. Climent; Javier Palau; Amparo Ruiz; Virtudes Soriano; Eduardo Aznar; Teres 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 23 KB